A detailed history of J. Safra Sarasin Holding Ag transactions in Eli Lilly & CO stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 93,469 shares of LLY stock, worth $77.8 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
93,469
Previous 70,919 31.8%
Holding current value
$77.8 Million
Previous $64.1 Billion 29.16%
% of portfolio
1.44%
Previous 1.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $17.4 Million - $21.6 Million
22,550 Added 31.8%
93,469 $82.8 Billion
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $51.4 Million - $64.5 Million
70,919 New
70,919 $64.1 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $791B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.